Loganathan Rangasamy
Overview
Explore the profile of Loganathan Rangasamy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
174
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fasogbon I, Ondari E, Tusubira D, Rangasamy L, Venkatesan J, Musyoka A, et al.
Anal Biochem
. 2024 Dec;
699():115756.
PMID: 39732319
Aptamers, single-stranded nucleic acids that bind to specific targets with high affinity and specificity, hold significant promise in various biomedical and biotechnological applications. The traditional method of aptamer selection, SELEX...
2.
Mamindla A, Murugan D, Varadhan M, Ajaykamal T, Rangasamy L, Palaniandavar M, et al.
RSC Adv
. 2024 Oct;
14(43):31704-31722.
PMID: 39376525
The promising biological applications of thiosemicarbazone derivatives have inspired the design, synthesis, and study of their Cu(ii) complexes for anticancer therapeutic applications. Herein, we have evaluated the DNA/protein binding, DNA...
3.
Venkatesan J, Murugan D, Lakshminarayanan K, Smith A, Vasanthakumari Thirumalaiswamy H, Kandhasamy H, et al.
Pharmacol Ther
. 2024 Sep;
263:108725.
PMID: 39322067
Targeted protein degradation (TPD) has emerged as a prominent and vital strategy for therapeutic intervention of cancers and other diseases. One such approach involves the exploration of proteolysis targeting chimeras...
4.
Lakshminarayanan K, Murugan D, Venkatesan J, Vasanthakumari Thirumalaiswamy H, Gadais C, Rangasamy L
ACS Infect Dis
. 2024 Jun;
10(8):2448-2466.
PMID: 38905481
Fungi pose a global threat to humankind due to the increasing emergence of multi-drug-resistant fungi. There is a rising incidence of invasive fungal infections. Due to the structural complexity of...
5.
Fasogbon I, Ondari E, Deusdedit T, Rangasamy L, Krishnan S, Aja P
Biol Methods Protoc
. 2024 Jun;
9(1):bpae034.
PMID: 38835856
Point-of-care (POC) field screening for tools for ( is still lacking due to the requirement for a simple, robust field-applicable test that does not entail specialized laboratory equipment. In accordance...
6.
Benny A, Thamim M, Srivastava P, Suresh S, Thirumoorthy K, Rangasamy L, et al.
RSC Adv
. 2024 Apr;
14(18):12278-12293.
PMID: 38633488
The Suzuki-Miyaura coupling is one of the ubiquitous method for the carbon-carbon bond-forming reactions in organic chemistry. Its popularity is due to its ability to undergo extensive coupling reactions to...
7.
Kartikeyan R, Murugan D, Ajaykamal T, Varadhan M, Rangasamy L, Velusamy M, et al.
Dalton Trans
. 2023 Jun;
52(26):9148-9169.
PMID: 37341481
Recently, mixed-ligand copper(II) complexes have received much attention in searching for alternative metallodrugs to cisplatin. A series of mixed ligand Cu(II) complexes of the type [Cu(L)(diimine)](ClO) 1-6, where the HL...
8.
Venkatesan J, Murugan D, Rangasamy L
Antibiotics (Basel)
. 2022 Dec;
11(12).
PMID: 36551374
Targeted protein degradation is a new aspect in the field of drug discovery. Traditionally, developing an antibiotic includes tedious and expensive processes, such as drug screening, lead optimization, and formulation....
9.
Murugan D, Rangasamy L
Mol Cell Biochem
. 2022 Nov;
478(7):1487-1518.
PMID: 36394787
COVID-19 has severely devastated many lives across the globe. It has been speculated that stem cell-based therapy for COVID-19 treatment could be able to subsidize the effects. In preclinical and...
10.
Murugan D, Murugesan V, Panchapakesan B, Rangasamy L
Cancers (Basel)
. 2022 Nov;
14(21).
PMID: 36358857
Natural killer (NK) cells are one of the first lines of defense against infections and malignancies. NK cell-based immunotherapies are emerging as an alternative to T cell-based immunotherapies. Preclinical and...